Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2026
Membrane Fusion-Mediated Cytosolic Delivery of Threose Nucleic Acids via Homotypic Nanoparticles Overcomes Drug Resistance in Triple-Negative Breast CancerWei Zheng, Tristan Juin Han Chang, Xinchao Li, et al.Cancer Cell International|June 11, 2026
FGD3 as a prognostic and immunological biomarker: a pan-cancer analysis of its role in tumor progression and the immune landscapeJing Zhu, Chun Yu, Xin Xu, et al.Journal of Materials Chemistry. B|February 4, 2022
An in situ spontaneously forming micelle-hydrogel system with programmable release for the sequential therapy of anaplastic thyroid cancerXi Yang, Lingyun Zhang, Lingnan Zheng, et al.Biomaterials|July 2, 2023
Antigenicity and adjuvanticity co-reinforced personalized cell vaccines based on self-adjuvanted hydrogel for post-surgical cancer vaccinationTao He, Yiling Shi, Xiaorong Kou, et al.Frontiers in Immunology|August 22, 2025
RAB5B: explore its carcinogenic potential and understand its role, prognostic value and biological significance in pan-cancerJing Zhu, Chun Yu, Xin Xu, et al.Biomaterials|December 24, 2023
A programmable releasing versatile hydrogel platform boosts systemic immune responses via sculpting tumor immunogenicity and reversing tolerogenic dendritic cellsWangxian Fu, Xinchao Li, Yingjie Li, et al.Journal of the American Chemical Society|August 29, 2022
Lanthanide-Nucleotide Coordination Nanoparticles for STING ActivationZichao Luo, Xiuqi Liang, Tao He, et al.Acta Pharmaceutica Sinica. B|March 6, 2023
A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrenceTao He, Mingxing Hu, Shunyao Zhu, et al.Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|January 29, 2016
[Compilation of a questionnaire on maternal and child health birth cohort study]Shan Tan, Hongyan Li, Xiao Gao, et al.Journal of Nanobiotechnology|February 3, 2026
Tumor-activated dual metabolic nanomodulator turns over tolerogenic tumor control and unleashes systemic immune responsesXiaorong Kou, Xue Wu, Tao He, et al.Pageof 5